Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects.
Saved in:
| Title: | Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. |
|---|---|
| Authors: | Vigneron SF; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Ohno S; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States., Braz J; Department of Anatomy, University of California, San Francisco, California 94158, United States., Kim JY; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Kweon OS; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States., Webb C; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Billesbølle CB; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Srinivasan K; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Bhardwaj K; Department of Anatomy, University of California, San Francisco, California 94158, United States., Irwin JJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Manglik A; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States., Basbaum AI; Department of Anatomy, University of California, San Francisco, California 94158, United States., Ellman JA; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States., Shoichet BK; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States. |
| Source: | ACS central science [ACS Cent Sci] 2025 Apr 29; Vol. 11 (5), pp. 770-790. Date of Electronic Publication: 2025 Apr 29 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ACS Publications Country of Publication: United States NLM ID: 101660035 Publication Model: eCollection Cited Medium: Print ISSN: 2374-7943 (Print) Linking ISSN: 23747943 NLM ISO Abbreviation: ACS Cent Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40454334 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vigneron+SF%22">Vigneron SF</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Ohno+S%22">Ohno S</searchLink>; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States.<br /><searchLink fieldCode="AU" term="%22Braz+J%22">Braz J</searchLink>; Department of Anatomy, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Kim+JY%22">Kim JY</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Kweon+OS%22">Kweon OS</searchLink>; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States.<br /><searchLink fieldCode="AU" term="%22Webb+C%22">Webb C</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Billesbølle+CB%22">Billesbølle CB</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Srinivasan+K%22">Srinivasan K</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Bhardwaj+K%22">Bhardwaj K</searchLink>; Department of Anatomy, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Irwin+JJ%22">Irwin JJ</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Manglik+A%22">Manglik A</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Basbaum+AI%22">Basbaum AI</searchLink>; Department of Anatomy, University of California, San Francisco, California 94158, United States.<br /><searchLink fieldCode="AU" term="%22Ellman+JA%22">Ellman JA</searchLink>; Department of Chemistry, Yale University, New Haven, Connecticut 06520, United States.<br /><searchLink fieldCode="AU" term="%22Shoichet+BK%22">Shoichet BK</searchLink>; Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101660035%22">ACS central science</searchLink> [ACS Cent Sci] 2025 Apr 29; Vol. 11 (5), pp. 770-790. <i>Date of Electronic Publication: </i>2025 Apr 29 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22ACS+Publications%22">ACS Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101660035 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2374-7943 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223747943%22">23747943 </searchLink><i>NLM ISO Abbreviation: </i>ACS Cent Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40454334 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acscentsci.5c00052 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 770 Titles: – TitleFull: Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vigneron SF – PersonEntity: Name: NameFull: Ohno S – PersonEntity: Name: NameFull: Braz J – PersonEntity: Name: NameFull: Kim JY – PersonEntity: Name: NameFull: Kweon OS – PersonEntity: Name: NameFull: Webb C – PersonEntity: Name: NameFull: Billesbølle CB – PersonEntity: Name: NameFull: Srinivasan K – PersonEntity: Name: NameFull: Bhardwaj K – PersonEntity: Name: NameFull: Irwin JJ – PersonEntity: Name: NameFull: Manglik A – PersonEntity: Name: NameFull: Basbaum AI – PersonEntity: Name: NameFull: Ellman JA – PersonEntity: Name: NameFull: Shoichet BK IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 04 Text: 2025 Apr 29 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2374-7943 Numbering: – Type: volume Value: 11 – Type: issue Value: 5 Titles: – TitleFull: ACS central science Type: main |
| ResultId | 1 |